These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38946272)

  • 1. The Role of Atypicals With Regard to Weight Gain in Bipolar Disorder Treatment: Response to Mattes.
    Najar H; Pålsson E; Landén M
    Am J Psychiatry; 2024 Jul; 181(7):658-659. PubMed ID: 38946272
    [No Abstract]   [Full Text] [Related]  

  • 2. The Role of Atypicals With Regard to Weight Gain in Bipolar Disorder Treatment.
    Mattes JA
    Am J Psychiatry; 2024 Jul; 181(7):658. PubMed ID: 38946281
    [No Abstract]   [Full Text] [Related]  

  • 3. Weight gain and metabolic issues of medicines used for bipolar disorder.
    Fagiolini A; Chengappa KN
    Curr Psychiatry Rep; 2007 Dec; 9(6):521-8. PubMed ID: 18221634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A naturalistic retrospective review of weight gain in bipolar patients treated with second generation antipsychotics.
    Worthington MA; El-Mallakh RS
    J Clin Psychopharmacol; 2015 Apr; 35(2):192-3. PubMed ID: 25587693
    [No Abstract]   [Full Text] [Related]  

  • 5. Weight gain with add-on second-generation antipsychotics in bipolar disorder: a naturalistic study.
    Najar H; Joas E; Kardell M; Pålsson E; Landén M
    Acta Psychiatr Scand; 2017 Jun; 135(6):606-611. PubMed ID: 28407229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olanzapine and pediatric bipolar disorder: evidence for efficacy and safety concerns.
    McClellan JM
    Am J Psychiatry; 2007 Oct; 164(10):1462-4. PubMed ID: 17898331
    [No Abstract]   [Full Text] [Related]  

  • 7. Weight gain in bipolar disorder: pharmacological treatment as a contributing factor.
    Torrent C; Amann B; Sánchez-Moreno J; Colom F; Reinares M; Comes M; Rosa AR; Scott J; Vieta E
    Acta Psychiatr Scand; 2008 Jul; 118(1):4-18. PubMed ID: 18498432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of available agents used to treat bipolar disorder: focus on weight gain.
    Nemeroff CB
    J Clin Psychiatry; 2003 May; 64(5):532-9. PubMed ID: 12755655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subjective Versus Objective Weight Gain During Acute Treatment With Second-Generation Antipsychotics in Schizophrenia and Bipolar Disorder.
    Gao K; Fang F; Wang Z; Calabrese JR
    J Clin Psychopharmacol; 2016 Dec; 36(6):637-642. PubMed ID: 27753728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical antipsychotic augmentation of mood stabilizer therapy in bipolar disorder.
    Bowden CL
    J Clin Psychiatry; 2005; 66 Suppl 3():12-9. PubMed ID: 15762830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asenapine (Saphris) sublingual tablets for schizophrenia and bipolar disorder.
    Med Lett Drugs Ther; 2010 Feb; 52(1331):9-10. PubMed ID: 20216523
    [No Abstract]   [Full Text] [Related]  

  • 12. Melatonin for Reducing Weight Gain Following Administration of Atypical Antipsychotic Olanzapine for Adolescents with Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Mostafavi SA; Solhi M; Mohammadi MR; Akhondzadeh S
    J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):440-444. PubMed ID: 28339282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive behavior therapy for weight gain.
    Umbricht D; Flury H; Bridler R
    Am J Psychiatry; 2001 Jun; 158(6):971. PubMed ID: 11384925
    [No Abstract]   [Full Text] [Related]  

  • 14. Substantial weight gain associated with severe carbohydrate craving in a patient receiving quetiapine.
    Kluge M; Dietzel J
    Psychiatry Clin Neurosci; 2013 Apr; 67(3):189-90. PubMed ID: 23581871
    [No Abstract]   [Full Text] [Related]  

  • 15. Weight gain and improvement with quetiapine in bipolar I disorder: a case report.
    Ozcan ME; Kaya B; Polat R
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):413-5. PubMed ID: 14751443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olanzapine/samidorphan (Lybalvi) for schizophrenia and bipolar disorder.
    Med Lett Drugs Ther; 2021 Nov; 63(1638):191-192. PubMed ID: 35085217
    [No Abstract]   [Full Text] [Related]  

  • 17. The safety and tolerability of atypical antipsychotics in bipolar disorder.
    Seemüller F; Forsthoff A; Dittmann S; Born C; Bernhard B; Severus WE; Grunze H
    Expert Opin Drug Saf; 2005 Sep; 4(5):849-68. PubMed ID: 16111448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight gain with atypical antipsychotic drugs in bipolar disorder.
    Callan JA; Howland RH; Puskar K
    J Psychosoc Nurs Ment Health Serv; 2009 Sep; 47(9):11-2. PubMed ID: 19772244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of atypical antipsychotics in rapid cycling bipolar disorder: a review of the literature.
    Zupancic ML
    Ann Clin Psychiatry; 2011 May; 23(2):141-9. PubMed ID: 21547275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness criterion: balancing efficacy against the risks of weight gain.
    Citrome L
    J Clin Psychiatry; 2007; 68 Suppl 12():12-7. PubMed ID: 17956151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.